This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

A Human In-vivo Model for the Detection of Inflammatory and Nociceptive Biomarkers

This study has been completed.
Information provided by (Responsible Party):
Martin Angst, Stanford University Identifier:
First received: September 14, 2005
Last updated: June 18, 2013
Last verified: June 2013
This study aims to establish a novel approach assisting the rational development of analgesic and anti-inflammatory drugs. In a first step we will test in healthy human volunteers whether proteins mediating inflammation and pain can be detected in an experimentally induced inflammatory skin lesion. Fluids that will be used to detect such proteins will be collected from the inflamed skin site via small porous catheters. We wish to establish the expression pattern of different proteins and correlate it with various tests assessing pain.

Condition Intervention
Skin Diseases Procedure: Micro-plasmapheresis

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double
Primary Purpose: Diagnostic
Official Title: Proof-of-concept Study for Bio-marker Assay Validation in Humans

Resource links provided by NLM:

Further study details as provided by Martin Angst, Stanford University:

Primary Outcome Measures:
  • Cytokine-release profile in response to inflammation, noxious heat, and asministration of a COX-inhibitor

Estimated Enrollment: 13

Ages Eligible for Study:   21 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:1. Age between 21-60. 2. Skin type II or III according to the classification of Fitzpatrick (II: fair skin, always burns, sometimes tans, III: medium skin, sometimes burns, always tans).
 Exclusion Criteria:1. History of a significant systemic disease, a dermatological disease, bleeding disorder, or chronic pain.

2. Consumption of analgesic drugs. 3. Hypersensitivity to sunlight.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00186563

United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
Martin Angst
Principal Investigator: Martin S Angst Stanford University
  More Information

Responsible Party: Martin Angst, Professor of Anesthesia, Stanford University Identifier: NCT00186563     History of Changes
Other Study ID Numbers: 79723
Study First Received: September 14, 2005
Last Updated: June 18, 2013

Additional relevant MeSH terms:
Skin Diseases processed this record on August 18, 2017